NiTi shape memory alloy helixes through the hydriding–dehydring method

Autor: Silvia Briseño Murguia, Laura Mello, Wendy Fisher, Yoav Snir, Arielle Clauser, Marcus L. Young, Heather Dunn

Publikováno v: Materialia. 5:100210

Shape memory alloys have been adopted in many industries, including the biomedical and electronic industries, due to their unique properties. Actuator design is one of the areas in which the thermomechanical properties of shape memory alloys have pla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6107690aafcbc33306e0b81467e75acd
https://doi.org/10.1016/j.mtla.2019.100210

Universal interfaces to multimedia documents

Autor: C. Rundle, I. Langer, Gerhard Weber, Helen Petrie, L. Pyfers, Keith Gladstone, Wendy Fisher

Publikováno v: ICMI

Electronic documents theoretically have great advantages for people with print disabilities, although currently this potential is not being realized. This paper reports research to develop multimedia documents with universal interfaces which can be c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2110f569bff380cb7d815b56bd6e55c
https://doi.org/10.1109/icmi.2002.1167015

Letters to the Editor

Autor: Wendy Fisher, Dennis E. Fehr

Publikováno v: Art Education. 46:6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::303216cc8a249ee278aa9127d1bc39a3
https://doi.org/10.2307/3193402

Effective delivery of Complex Innovative Design (CID) cancer trials-A consensus statement.

Autor: Blagden SP; Department of Oncology, University of Oxford, Oxford, UK. sarah.blagden@oncology.ox.ac.uk., Billingham L; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Studies, University of Birmingham, Birmingham, UK., Brown LC; Medical Research Council (MRC) Clinical Trials Unit, University College London, London, UK., Buckland SW; Pfizer, Surrey, UK., Cooper AM; The Association of the British Pharmaceutical Industry (ABPI), London, UK., Ellis S; Health Research Authority, London, UK., Fisher W; Wendy Fisher Consulting (WFC) Ltd, London, UK., Hughes H; Cardiff and Vale University Health Board, Cardiff, UK., Keatley DA; Independent Cancer Patients' Voice, National Cancer Research Institute (NCRI), London, UK., Maignen FM; National Institute for Health and Care Excellence (NICE), London, UK., Morozov A; Pfizer, New York, USA., Navaie W; Health Research Authority, London, UK., Pearson S; Oncology Clinical Trials Office, University of Oxford, Oxford, UK., Shaaban A; Queen Elizabeth Hospital Birmingham and the University of Birmingham, Birmingham, UK., Wydenbach K; Medicines and Healthcare products Regulatory Agency (MHRA), London, UK., Kearns PR; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Studies, University of Birmingham, Birmingham, UK.; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Cancer and Genomic Studies, University of Birmingham, Birmingham, UK.

Publikováno v: British journal of cancer [Br J Cancer] 2020 Feb; Vol. 122 (4), pp. 473-482. Date of Electronic Publication: 2020 Jan 06.